Your session is about to expire
← Back to Search
Supramarginal Resection for Brain Cancer (G-SUMIT Trial)
G-SUMIT Trial Summary
This trial is to see if removing more of the tumor results in better outcomes for patients with HGG.
G-SUMIT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowG-SUMIT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.G-SUMIT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new participants being considered for this experiment?
"Indeed, according to the clinicaltrials.gov website, this medical study is currently enrolling participants. First posted on February 5th 2021 and most recently updated on May 5th 2022, the trial seeks 72 patients at a single location."
Is the minimum age requirement for this research project 20 or above?
"To be eligible for this clinical trial, patients must be aged between 18 to 80 years old."
Who has the opportunity to take part in this research study?
"This trial is searching for 72 individuals suffering from glioma between 18 and 80 years of age. To be eligible, applicants must meet the following qualifications: comprehension and consent to study enrollment provided by either patient or their SDM, radiographic verification of a gadolinium-enhancing intra-axial tumour compatible with HGG, minimum KPS score of 60, safe anatomical location of neoplasm."
What is the largest size of the total participant pool for this clinical investigation?
"Affirmative. According to clinicaltrials.gov, this medical trial remains open for recruitment and has been amended on May 5th 2022 since its initial listing of February 5th 2021. At the moment, 72 participants are needed from one particular site."
Share this study with friends
Copy Link
Messenger